Anticancer activity of curcumin-loaded nanocarriers: A focus on combined therapeutic modalities

Basit Öğe Kaydı
dc.contributor.authorSenturk, Fatih
dc.contributor.authorYasar, Huriye
dc.contributor.authorBahadir, Anzel
dc.contributor.authorÇakmak, Soner
dc.date.accessioned2025-10-11T20:45:20Z
dc.date.available2025-10-11T20:45:20Z
dc.date.issued2025
dc.departmentDüzce Üniversitesien_US
dc.description.abstractCurcumin (CUR) is a polyphenolic compound known for its various therapeutic effects, including antioxidant, antiinflammatory, and anticancer activities. Researchers have elucidated several molecular and cellular pathways through which CUR exhibits potent anticancer activity, rendering it a promising candidate for cancer therapy. The activity of CUR is attributed to three reactive functional groups: the diketone moiety and two phenolic groups. Particularly, the presence of hydroxyl (OH) groups in the phenolic ring is responsible for CUR's anticancer effects. However, the therapeutic efficacy of CUR is restricted by its hydrophobic nature, rapid degradation with a short half-life, and low bioavailability. To address these challenges, researchers have developed nano-based drug carrier systems, such as nanoparticles, liposomes, and micelles, to encapsulate and deliver CUR effectively. These nanocarriers can be customized in size, chemical composition, surface charge, and functionalization to enable targeted delivery to specific sites. Also, the surface functionalities of nanocarriers can be tailored to specific targets, such as overexpressed receptors on cancer cells, leading to improved cellular uptake and therapeutic outcomes of CUR. Furthermore, integrating CUR-loaded nanocarriers with other therapeutic modalities, such as chemotherapy (CUR and chemotherapeutic agents coloaded), magnetic nanohyperthermia, photodynamic therapy, and nanocarrier-based ultrasound therapy, holds promise for enhancing treatment efficacy. This chapter provides an extensive overview of the molecular pathways and underlying mechanisms responsible for the substantial anticancer activity of CUR. In addition, it highlights the utilization of CUR-loaded nanocarriers in combination with other therapeutic modalities to achieve enhanced efficacy in cancer therapy. The combination of CUR with other modalities has demonstrated promising results in preclinical studies, indicating the potential for a synergistic effect. © 2025 Elsevier B.V., All rights reserved.en_US
dc.identifier.doi10.1016/B978-0-443-23752-2.00014-1
dc.identifier.endpage39en_US
dc.identifier.isbn9780444632944
dc.identifier.isbn9780444626158
dc.identifier.isbn9780444634306
dc.identifier.isbn9780444640574
dc.identifier.isbn9780444596031
dc.identifier.isbn9780444636034
dc.identifier.isbn9780444639325
dc.identifier.isbn9780444636027
dc.identifier.isbn9780444632814
dc.identifier.issn1572-5995
dc.identifier.scopus2-s2.0-85218995751en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage1en_US
dc.identifier.urihttps://doi.org/10.1016/B978-0-443-23752-2.00014-1
dc.identifier.urihttps://hdl.handle.net/20.500.12684/21285
dc.identifier.volume84en_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherElsevier B.V.en_US
dc.relation.ispartofStudies in Natural Products Chemistryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmzKA_Scopus_20250911
dc.subjectAnticancer Activityen_US
dc.subjectBioavailabilityen_US
dc.subjectCombined Therapyen_US
dc.subjectCurcuminen_US
dc.subjectNanocarriersen_US
dc.titleAnticancer activity of curcumin-loaded nanocarriers: A focus on combined therapeutic modalitiesen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu